{
  "docId": "019de075-e061-72f9-baa2-90171b05eced",
  "docSlug": "cdaaa50efb264b4a4093f665bafb20a4",
  "documentTitle": "Absci | Investor Presentation Deck | 111 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 97,
  "pageCount": 111,
  "prevPage": 96,
  "nextPage": 98,
  "slideType": "thesis_headline",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "Includes a biological pathway diagram (Takedatsu 2008) and market data points.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e061-72f9-baa2-90171b05eced/97",
  "deckHref": "/decks/019de075-e061-72f9-baa2-90171b05eced",
  "deckJsonHref": "/decks/019de075-e061-72f9-baa2-90171b05eced.json",
  "deckAnchorHref": "/decks/019de075-e061-72f9-baa2-90171b05eced#slide-97",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.28,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Biological pathway diagram showing TL1A interaction with IL-12 and IL-23",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c78da536-85d3-40e5-831a-b91db5a2a44c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.63,
        "x": 0.33,
        "y": 0.7
      },
      "kind": "list",
      "text": "TL1A is implicated in multiple inflammatory and fibrotic diseases beyond IBD: Rheumatoid Arthritis, Psoriasis, Liver Fibrosis, Atopic Dermatitis, Intestinal Fibrosis, Lupus Erythematosus, Pulmonary Fibrosis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d568b81-07eb-4077-8292-af6c53e414f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.63,
        "x": 0.33,
        "y": 0.25
      },
      "kind": "list",
      "text": "IBD is currently a ~$24B market worldwide, expected to grow to ~$29B in 2028. Sales dominated by biologics. Phase 2 data from Prometheus and Roivant validate MoA. TL1A drove a recent high-value deal: Prometheus acquired for $10.8B by Merck.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47ba8b71-543c-4dcd-ba24-c0b815bd60f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "TL1A Antagonism has the potential to become a blockbuster in inflammation and fibrosis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "610ea50c-46c6-4c59-9df4-68fd9b5451eb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}